AM-0902
CAS No. 1883711-97-4
AM-0902 ( —— )
Catalog No. M21665 CAS No. 1883711-97-4
AM-0902 is a potent and specific TRPA1 antagonist (IC50s: 71/131 nM for rTRPA1 and hTRPA1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 69 | In Stock |
|
10MG | 96 | In Stock |
|
25MG | 200 | In Stock |
|
50MG | 389 | In Stock |
|
100MG | 575 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAM-0902
-
NoteResearch use only not for human use.
-
Brief DescriptionAM-0902 is a potent and specific TRPA1 antagonist (IC50s: 71/131 nM for rTRPA1 and hTRPA1).
-
DescriptionAM-0902 is a potent and specific TRPA1 antagonist (IC50s: 71/131 nM for rTRPA1 and hTRPA1).
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRPA1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1883711-97-4
-
Formula Weight370.79
-
Molecular FormulaC17H15ClN6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 145 mg/mL (391.05 mM; Need ultrasonic and warming)
-
SMILESCn(cn1)c2c1N=CN(Cc1nc(CCc(cc3)ccc3Cl)no1)C2=O
-
Chemical Name1-((3-(4-chlorophenethyl)-124-oxadiazol-5-yl)methyl)-7-methyl-17-dihydro-6H-purin-6-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schenkel LB et al. Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1)Antagonists Demonstrating Potent in Vivo Activity. J Med Chem. 2016 Mar 24;59(6):2794-809.
molnova catalog
related products
-
SKF-96365 hydrochlor...
SKF-96365, an SOCE inhibitor, exhibits potent anti-neoplastic activity by inducing cell-cycle arrest and apoptosis in colorectal Y cells.
-
Clemizole hydrochlor...
An H1 histamine receptor antagonist that substantially inhibits HCV replication by suppression of NS4B's RNA binding (IC50=24 nM) with little toxicity for the host cells.
-
ASP7663
ASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?